COMBANTRIN

This brand name is authorized in Austria, Canada, France, Japan, Mexico, New Zealand, South Africa

Active ingredients

The drug COMBANTRIN contains one active pharmaceutical ingredient (API):

1 Pyrantel UNII 81BK194Z5M - PYRANTEL PAMOATE

Pyrantel acts as a cholinergic agonist. Its mode of action is to stimulate nicotinic cholinergic receptors of the parasite, induce spastic paralysis of the nematodes and thereby allow removal from the gastro intestinal (GI) system by peristalsis. Read about Pyrantel

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
P02CC01	Pyrantel	P Antiparasitic products, insecticides and repellents → P02 Anthelmintics → P02C Antinematodal agents → P02CC Tetrahydropyrimidine derivatives
Discover more medicines within P02CC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 01944363
Country: FR	Base de données publique des médicaments	Identifier(s): 61429046, 69990800
Country: JP	医薬品医療機器総合機構	Identifier(s): 6429001F1036, 6429001R1032
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 76803, 76888
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 1545
Country: ZA	Health Products Regulatory Authority	Identifier(s): D/12/260, J/12/200